pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 1
    QX-027N
    Chronic Obstructive Pulmonary Disease (COPD) Windward Bio AG
  • Preclinical
    QX-031N
    Unspecified Respiratory Disorders F. Hoffmann-La Roche Ltd
  • Preclinical
    QX-035N
    Unspecified Respiratory Disorders JiangSu Qyuns Therapeutics Co Ltd
  • Phase 1
← prev
page 125 of 231
next →
131
Pain89
Neurology1
QXL-138AM
Gastrointestinal Tract Cancer
Nammi Therapeutics Inc
  • Preclinical
    QY-301
    Crohn's Disease (Regional Enteritis) E-nitiate Biopharmaceuticals (Hangzhou) Co Ltd
  • Marketed
    Quillivant XR
    Quillivant XR (methylphenidate hydrochloride)
    Attention Deficit Hyperactivity Disorder (ADHD) Tris Pharma Inc
  • Marketed
    Qvar Redihaler
    Qvar Redihaler (beclomethasone dipropionate)
    Asthma Teva Respiratory LLC
  • Phase 1
    R-2487
    Rheumatoid Arthritis Rise Therapeutics LLC
  • Phase 2
    R-289
    Myelodysplastic Syndrome (Preleukemia)$RIGL RIGEL PHARMACEUTICALS INC
  • Phase 2
    R-327
    Urinary Tract Infections Recce Pharmaceuticals Ltd
  • Phase 1
    R-3750
    Ulcerative Colitis Rise Therapeutics LLC
  • Phase 1
    R-5780
    Basal Cell Carcinoma (Basal Cell Epithelioma) Rise Therapeutics LLC
  • Phase 1
    RAB-001d
    Osteoarthritis Zhongshan RabPharma Biopharmaceutical Co Ltd
  • Phase 2
    RABI-767
    Pancreatitis Lamassu Pharma LLC
  • Preclinical
    RAD-302
    Pancreatic Ductal Adenocarcinoma$RADX Radiopharm Theranostics Ltd
  • RADIOGARDASE
    RADIOGARDASE (PRUSSIAN BLUE INSOLUBLE CAPSULES)
    no indication HEYL CHEMISCH
  • Preclinical
    RAG-21
    Amyotrophic Lateral Sclerosis Ractigen Therapeutics Inc
  • Phase 2
    RAGE Inhibitor
    Coronavirus Disease 2019 (COVID-19) Galactica Pharmaceuticals Inc
  • RALDESY TM
    RALDESY TM (TRAZODONE HYDROCHLORIDE ORAL)
    no indication KAMAT
  • RANITIDINE
    RANITIDINE
    no indication AMNEAL PHARMS NY
  • Preclinical
    RAP-103
    Dementia Associated With Alzheimer's Disease Creative Bio-Peptides Inc
  • Phase 2
    RAP-219
    Bipolar I Disorder$RAPP Rapport Therapeutics, Inc.
  • Phase 2
    RAPA-201
    Refractory Multiple Myeloma Rapa Therapeutics LLC
  • Phase 2
    RB-601
    Head And Neck Cancer Radiance Biopharma Inc
  • Preclinical
    RBIO-101
    no indication Reflection Biotechnologies Ltd
  • Phase 1
    RBM-001
    Coronavirus Disease 2019 (COVID-19) Rock Biomedical Inc
  • Phase 1
    RCI-001
    Keratoconjunctivitis Sicca (Dry Eye) Rudacure Co Ltd
  • Phase 1
    RCT-1100
    Primary Ciliary Dyskinesia Recode Therapeutics Inc
  • Phase 2
    RCT-2100
    Cystic Fibrosis Recode Therapeutics Inc
  • Phase 2
    RD-1302
    T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphobla… Imviva Biotech